AKT1 and glioma: Exosomal MIF (migration inhibitory factor) inhibited the PI3K/AKT signaling pathway by upregulating metalloprotease inhibitor 3 (TIMP 3) and enhanced the TMZ sensitivity of drug-resistant glioma cells [79].